View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Pelham Smithers
  • Pelham Smithers

PSA Media and Entertainment: Sony (6758 JT) FY25 Q3 Review and Outlook

Sony’s FY25 Q3 performance came in ahead of consensus but the shares barely moved. Pelham Smithers reviews the performance and assesses the positives and negatives ahead.

Alicia Reese ... (+3)
  • Alicia Reese
  • Kade Barr
  • Matthew McCartney
Alicia Reese ... (+3)
  • Alicia Reese
  • Kade Barr
  • Matthew McCartney
Pelham Smithers
  • Pelham Smithers

PSA Media & Technology: Nintendo (7974 JT) – FY25 Q3 Review

Pelham Smithers explains why there’s not much to be happy about for Nintendo’s Q3, nor the full-year FY25 outlook.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SRPT SAREPTA THERAPEUTICS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
PANW PALO ALTO NETWORKS INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
NFLX NETFLIX INC.
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
WVE WAVE LIFE SCIENCES
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
GOSS GOSSAMER BIO
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ZNTL KEROS THERAPEUTICS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
DASH TRAVERE THERAPEUTICS INC
VRDN DOORDASH
PLTK VIRIDIAN THERAPEUTICS INC
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
EWTX TYRA BIOSCIENCES INC
SLDB EDGEWISE THERAPEUTICS INC
APGE SOLID BIOSCIENCES INC
DNTH APOGEE THERAPEUTICS INC
CGON DIANTHUS THERAPEUTICS INC
ORKA CG ONCOLOGY INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
JADE BIOSCIENCES INC
Alicia Reese ... (+3)
  • Alicia Reese
  • Kade Barr
  • Matthew McCartney
Alicia Reese ... (+3)
  • Alicia Reese
  • Kade Barr
  • Matthew McCartney
Pelham Smithers
  • Pelham Smithers

PSA Media & Entertainment: Capcom (9697 JT) FY25 Q3 OP +45% YoY, Beats...

Pelham Smithers reviews Capcom’s FY25 Q3 performance and discusses what to expect for the Q4 and full-year results.

Alicia Reese ... (+3)
  • Alicia Reese
  • Kade Barr
  • Matthew McCartney
Pelham Smithers
  • Pelham Smithers

PSA Media & Entertainment: Nintendo (7974 JT) FY25 Q3 Preview

Ahead of Nintendo’s FY25 Q3 results on 4 Feb, analyst Pelham Smithers previews what to watch out for – and it’s not all fun and games.

Pelham Smithers
  • Pelham Smithers

PSA Media & Entertainment: Capcom (9697 JT) Makes Resident Evil Requie...

Issues with the performance of Monster Hunter Wilds following DLC updates may not have impacted earnings performance, but they soured what would otherwise have been an impressive outing for Requiem at both Gamescom and TGS, and while Capcom’s results have been fine, Pelham Smithers addresses the concern that Requiem’s launch next month will be hurt by the same problems as befallen Monster Hunter Wilds.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Take-Two Interactive Software, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 9 January 2026 in which we reassessed the appropriateness of the rating...

Pelham Smithers
  • Pelham Smithers

PSA Consumer Electronics: The Memory Trap – Outlook for Sony in 2026

Thanks to higher memory prices, Sony has a tough couple of years ahead, which is a pity, because the firm’s achievements in FY25 should have set it on a path to solid earnings growth in both years. Problematically, Sony is now heavily exposed to decisions by others – notably Apple’s iPhone pricing – and the outlook could be considerably worse than Pelham Smithers outlines in this earnings preview for FY25 and beyond.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch